Abstract

Theoretical models often differ significantly from measured data in their predictions of the magnitude of nuclear reactions that produce radionuclides for medical, research, and national security applications. In this paper, we compare a priori predictions from several state-of-the-art reaction modeling packages (CoH, EMPIRE, TALYS, and ALICE) to cross sections measured using the stacked-target activation method. The experiment was performed using the Lawrence Berkeley National Laboratory 88-Inch Cyclotron with beams of 25 and 55 MeV protons on a stack of iron, copper, and titanium foils. Thirty-four excitation functions were measured from 4–55 MeV, including the first measurement of the independent cross sections for ^{mathrm{nat}}hbox {Fe}(p,x)^{49,51}hbox {Cr}, ^{51,{mathrm{52m}},{mathrm{52g}},56}hbox {Mn}, and ^{{mathrm{58m,58g}}}hbox {Co}. All of the models, using default input parameters to assess their predictive capabilities, failed to reproduce the isomer-to-ground state ratio for reaction channels at compound and pre-compound energies, suggesting issues in modeling the deposition or distribution of angular momentum in these residual nuclei.

Highlights

  • Clinical practice of nuclear medicine is rapidly growing with the inclusion of a broader array of radiopharmaceuticals

  • For the natFe(p,x)51Mn reactions, seen in Fig. 4, the lower-energy 54Fe(p,α)51Mn reaction, which peaks around 15 MeV, is well-modeled by TALYS and TENDL and over-predicted by the default calculation performed with EMPIRE, CoH, and ALICE

  • We report the highest precision measurement of natFe(p,x)54Mn in this energy region. This measurement is consistent with earlier work aside from the globally-discrepant Williams data, as discussed previously. Modeling of these channels presents a counterpoint to the 51,52Mn results discussed earlier — 54Mn is well-modeled by CoH, TENDL, and TALYS, though EMPIRE overestimates the peak cross section by approximately 25%, and ALICE underestimates by the same, in addition to peaking approximately 3 MeV higher

Read more

Summary

Introduction

Clinical practice of nuclear medicine is rapidly growing with the inclusion of a broader array of radiopharmaceuticals. Given the pre-clinical success of many new and emerging radionuclides. The physical and chemical properties of these novel radionuclides tend

Experimental methods and materials
Stacked-target design
Proton fluence determination
Proton transport calculations
Calculation of measured cross sections
Results and discussion
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call